{"search_session":{},"preferences":{"l":"en","queryLanguage":"en"},"patentId":"149-915-646-694-005","frontPageModel":{"patentViewModel":{"ref":{"entityRefType":"PATENT","entityRefId":"149-915-646-694-005"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":11663,"type":"PATENT","title":"University of Montreal - Patent Portfolio","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":2579,"tags":[],"user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"notes":[{"id":8327,"type":"COLLECTION","user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"text":"
Search Applicants and Owners separately:uni* montreal
Select more for logical variants.
Add to collection.
Select all patents in the collection and expand by simple families.
Add to collection. Total patents: 1939
Search Applicants and Owners separately:uni* montreal
Select more for logical variants.
Add to collection.
Select all patents in the collection and expand by simple families.
Add to collection. Total patents: 1939
Xaa1 is Val, Thr or Ile;\n
Xaa3 is Lys or GIu;\n
Xaa4 is Lys or GIu;\n
Xaa5 is Ala or Gln;\n
Xaa7 is Thr or Pro;\n
Xaa8 is Gly, Ser or Val;\n
Xaa9 is Lys, VaI, Ile or Asn;\n
Xaa10 is GIu or Val;\n
Xaa11 is Lys or Asn;\n
Xaa12 is Gly, Glu or Asp;\n
Xaa13 is Asn or Met;\n
Xaa14 is Ile, Ala or Val;\n
Xaa15 is Glu or Val;\n
Xaa16 is Pro or Thr;\n
Xaa18 is Glu or Gln;\n
Xaa19 is Lys or Glu;\n
Xaa22 is Thr or Ala;\n
Xaa26 is Lys or Asn;\n
Xaa27 is Asp or Glu;\n
Xaa28 is Asn or Lys;\n
Xaa29 is Ile or Val and\n
Xaa30 is Glu or Val."],"number":2,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide of claim 1, comprising the amino acid sequence as set forth in SEQ ID NO 10."],"number":3,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide of claim 1, comprising an amino acid having at least 85% identity to the amino acid sequence set forth in SEQ ID NO 1 or in SEQ ID NO 4."],"number":4,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide of claim 1, comprising an amino acid sequence having at least 95% identity to the amino acid sequence set forth in SEQ ID NO 1."],"number":5,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide of claim 1, comprising an amino acid sequence having at least 95% identity to the amino acid sequence set forth in SEQ ID NO 4."],"number":6,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide of claim 1, wherein it elicits a protective response to a Streptococcus suis strain challenge when administered to an animal."],"number":7,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide of claim 3, comprising at least one repetitive amino acid sequence consisting of the amino acid sequence Xaa1 Ser Xaa3 Xaa4 Xaa5 Met Xaa7 Xaa8 Xaa9 Xaa10 Xaa11 Xaa12 Xaa13 Xaa14 Xaa15 Xaa16 Pro Xaa18 Xaa19 Gln Met Xaa22 Asn Lys Glu Xaa26 Xaa27 Xaa28 Xaa29 Xaa30 (SEQ ID NO 9) wherein\n
Xaa1 is Val, Thr or Ile;\n
Xaa3 is Lys or GIu;\n
Xaa4 is Lys or GIu;\n
Xaa5 is Ala or Gln;\n
Xaa7 is Thr or Pro;\n
Xaa8 is Gly, Ser or Val;\n
Xaa9 is Lys, VaI, Ile or Asn;\n
Xaa10 is GIu or Val;\n
Xaa11 is Lys or Asn;\n
Xaa12 is Gly, Glu or Asp;\n
Xaa13 is Asn or Met;\n
Xaa14 is Ile, Ala or Val;\n
Xaa15 is Glu or Val;\n
Xaa16 is Pro or Thr;\n
Xaa18 is Glu or Gln;\n
Xaa19 is Lys or Glu;\n
Xaa22 is Thr or Ala;\n
Xaa26 is Lys or Asn;\n
Xaa27 is Asp or Glu;\n
Xaa28 is Asn or Lys;\n
Xaa29 is Ile or Val and\n
Xaa30 is Glu or Val."],"number":8,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide of claim 4, comprising at least one repetitive amino acid sequence consisting of the amino acid sequence Xaa1 Ser Xaa3 Xaa4 Xaa5 Met Xaa7 Xaa8 Xaa9 Xaa10 Xaa11 Xaa12 Xaa13 Xaa14 Xaa15 Xaa16 Pro Xaa18 Xaa19 Gln Met Xaa22 Asn Lys Glu Xaa26 Xaa27 Xaa28 Xaa29 Xaa30 (SEQ ID NO 9) wherein\n
Xaa1 is Val, Thr or Ile;\n
Xaa3 is Lys or GIu;\n
Xaa4 is Lys or GIu;\n
Xaa5 is Ala or Gln;\n
Xaa7 is Thr or Pro;\n
Xaa8 is Gly, Ser or Val;\n
Xaa9 is Lys, VaI, Ile or Asn;\n
Xaa10 is GIu or Val;\n
Xaa11 is Lys or Asn;\n
Xaa12 is Gly, Glu or Asp;\n
Xaa13 is Asn or Met;\n
Xaa14 is Ile, Ala or Val;\n
Xaa15 is Glu or Val;\n
Xaa16 is Pro or Thr;\n
Xaa18 is Glu or Gln;\n
Xaa19 is Lys or Glu;\n
Xaa22 is Thr or Ala;\n
Xaa26 is Lys or Asn;\n
Xaa27 is Asp or Glu;\n
Xaa28 is Asn or Lys;\n
Xaa29 is Ile or Val and\n
Xaa30 is Glu or Val."],"number":9,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide of claim 5, comprising at least one repetitive amino acid sequence consisting of the amino acid sequence Xaa1 Ser Xaa3 Xaa4 Xaa5 Met Xaa7 Xaa8 Xaa9 Xaa10 Xaa11 Xaa12 Xaa13 Xaa14 Xaa15 Xaa16 Pro Xaa18 Xaa19 Gln Met Xaa22 Asn Lys Glu Xaa26 Xaa27 Xaa28 Xaa29 Xaa30 (SEQ ID NO 9) wherein\n
Xaa1 is Val, Thr or Ile;\n
Xaa3 is Lys or GIu;\n
Xaa4 is Lys or GIu;\n
Xaa5 is Ala or Gln;\n
Xaa7 is Thr or Pro;\n
Xaa8 is Gly, Ser or Val;\n
Xaa9 is Lys, VaI, Ile or Asn;\n
Xaa10 is GIu or Val;\n
Xaa11 is Lys or Asn;\n
Xaa12 is Gly, Glu or Asp;\n
Xaa13 is Asn or Met;\n
Xaa14 is Ile, Ala or Val;\n
Xaa15 is Glu or Val;\n
Xaa16 is Pro or Thr;\n
Xaa18 is Glu or Gln;\n
Xaa19 is Lys or Glu;\n
Xaa22 is Thr or Ala;\n
Xaa26 is Lys or Asn;\n
Xaa27 is Asp or Glu;\n
Xaa28 is Asn or Lys;\n
Xaa29 is Ile or Val and\n
Xaa30 is Glu or Val."],"number":10,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide of claim 6, comprising at least one repetitive amino acid sequence consisting of the amino acid sequence Xaa1 Ser Xaa3 Xaa4 Xaa5 Met Xaa7 Xaa8 Xaa9 Xaa10 Xaa11 Xaa12 Xaa13 Xaa14 Xaa15 Xaa16 Pro Xaa18 Xaa19 Gln Met Xaa22 Asn Lys Glu Xaa26 Xaa27 Xaa28 Xaa29 Xaa30 (SEQ ID NO 9) wherein\n
Xaa1 is Val, Thr or Ile;\n
Xaa3 is Lys or GIu;\n
Xaa4 is Lys or GIu;\n
Xaa5 is Ala or Gln;\n
Xaa7 is Thr or Pro;\n
Xaa8 is Gly, Ser or Val;\n
Xaa9 is Lys, VaI, Ile or Asn;\n
Xaa10 is GIu or Val;\n
Xaa11 is Lys or Asn;\n
Xaa12 is Gly, Glu or Asp;\n
Xaa13 is Asn or Met;\n
Xaa14 is Ile, Ala or Val;\n
Xaa15 is Glu or Val;\n
Xaa16 is Pro or Thr;\n
Xaa18 is Glu or Gln;\n
Xaa19 is Lys or Glu;\n
Xaa22 is Thr or Ala;\n
Xaa26 is Lys or Asn;\n
Xaa27 is Asp or Glu;\n
Xaa28 is Asn or Lys;\n
Xaa29 is Ile or Val and\n
Xaa30 is Glu or Val."],"number":11,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide of claim 1, comprising an amino acid sequence having 100% identity to the amino acid sequence set forth in SEQ ID NO 1."],"number":12,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide of claim 1, comprising an amino acid sequence having 100% identity to the amino acid sequence set forth in of SEQ ID NO 4."],"number":13,"annotation":false,"title":false,"claim":true},{"lines":["An isolated polypeptide, comprising an amino acid sequence having at least 95% identity to the amino acid sequence set forth in of SEQ ID NO 2, where said polypeptide does not have the amino acid sequence of SEQ ID NO: 10."],"number":14,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide of claim 14, comprising an amino acid sequence having 100% identity to the amino acid sequence set forth in of SEQ ID NO 2."],"number":15,"annotation":false,"title":false,"claim":true},{"lines":["An isolated polypeptide, comprising an amino acid sequence having at least 95% identity to the amino acid sequence set forth in of SEQ ID NO 3, where said polypeptide does not have the amino acid sequence of SEQ ID NO: 10."],"number":16,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide of claim 16, comprising an amino acid sequence having 100% identity to the amino acid sequence set forth in of SEQ ID NO 3."],"number":17,"annotation":false,"title":false,"claim":true},{"lines":["A composition comprising an acceptable carrier and at least one of the following elements: a polypeptide as defined in any one of claims 1, 2, 3, 4, 5, 6, 7, and 8 to 17 of claim 1."],"number":18,"annotation":false,"title":false,"claim":true},{"lines":["A composition for eliciting an immune response to Streptococcus or treating Streptococcus suis-associated diseases or infection caused by S. suis, comprising an acceptable carrier and at least one of the following elements: a polypeptide as defined in any one of claims 1, 2, 3, 4, 5, 6, 7, and 8 to 17 of claim 1."],"number":19,"annotation":false,"title":false,"claim":true},{"lines":["The composition of claim 19, further comprising an adjuvant."],"number":20,"annotation":false,"title":false,"claim":true},{"lines":["An isolated polypeptide fragment of the polypeptide of SEQ ID NO: 4, having at least 15 contiguous amino acid residues of the amino acid sequence of SEQ ID NO: 4."],"number":21,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide fragment of claim 21, having at least 25 contiguous amino acid residues of the amino acid sequence of SEQ ID NO: 4."],"number":22,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide fragment of claim 21, having at least 35 contiguous amino acid residues of the amino acid sequence of SEQ ID NO: 4."],"number":23,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide fragment of claim 21, further including a fusion tag at the N-terminal end thereof."],"number":24,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide fragment of claim 21, further including at the C-terminal end thereof a repetitive sequence consisting of the amino acid sequence of SEQ ID NO: 9."],"number":25,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide fragment of claim 25, wherein said repetitive sequence is a first repetitive sequence of a plurality of said repetitive sequence."],"number":26,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide fragment of claim 22, further including at the C-terminal end thereof a repetitive sequence consisting of the amino acid sequence of SEQ ID NO: 9."],"number":27,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide fragment of claim 27, wherein said repetitive sequence is a first repetitive sequence of a plurality of said repetitive sequence."],"number":28,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide fragment of claim 23, further including at the C-terminal end thereof a repetitive sequence consisting of the amino acid sequence of SEQ ID NO: 9."],"number":29,"annotation":false,"title":false,"claim":true},{"lines":["The isolated polypeptide fragment of claim 29, wherein said repetitive sequence is a first repetitive sequence of a plurality of said repetitive sequence."],"number":30,"annotation":false,"title":false,"claim":true}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}